Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth G Saag

Showing results (361-370 of 374) with videos related to

Pageof 38
Sort By:
Arthritis Care & Research|November 8, 2015
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid ArthritisJasvinder A Singh, Kenneth G Saag, S Louis Bridges, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 8, 2015
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid ArthritisJasvinder A Singh, Kenneth G Saag, S Louis Bridges, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 22, 2017
Brief Report: Validation of a Definition of Flare in Patients With Established GoutAngelo L Gaffo, Nicola Dalbeth, Kenneth G Saag, et al.
The Journal of Rheumatology|May 3, 2020
Flare Rate Thresholds for Patient Assessment of Disease Activity States in GoutWilliam Taylor, Nicola Dalbeth, Kenneth G Saag, et al.
Contemporary Clinical Trials Communications|July 26, 2016
A multi-modal intervention for Activating Patients at Risk for Osteoporosis (APROPOS): Rationale, design, and uptake of online study intervention materialMaria I Danila, Ryan C Outman, Elizabeth J Rahn, et al.
Plos Medicine|May 9, 2019
Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trialJasvinder A Singh, Liana Fraenkel, Candace Green, et al.
Arthritis Care & Research|April 5, 2012
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritisJasvinder A Singh, Daniel E Furst, Aseem Bharat, et al.
The Lancet. Diabetes & Endocrinology|November 3, 2019
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension studyMichael R McClung, Michelle L O'Donoghue, Socrates E Papapoulos, et al.
Annals of the Rheumatic Diseases|January 24, 2020
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 updateJosef S Smolen, Robert B M Landewé, Johannes W J Bijlsma, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 4, 2025
Asia-Pacific consensus for the management of osteoporosis in menChun-Feng Huang, Cheng-Jung Ho, Sung-Yen Lin, et al.
Pageof 38

Showing results (361-370 of 374) with videos related to

Sort By:
Pageof 38
Arthritis Care & Research|November 8, 2015
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid ArthritisJasvinder A Singh, Kenneth G Saag, S Louis Bridges, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 8, 2015
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid ArthritisJasvinder A Singh, Kenneth G Saag, S Louis Bridges, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 22, 2017
Brief Report: Validation of a Definition of Flare in Patients With Established GoutAngelo L Gaffo, Nicola Dalbeth, Kenneth G Saag, et al.
The Journal of Rheumatology|May 3, 2020
Flare Rate Thresholds for Patient Assessment of Disease Activity States in GoutWilliam Taylor, Nicola Dalbeth, Kenneth G Saag, et al.
Contemporary Clinical Trials Communications|July 26, 2016
A multi-modal intervention for Activating Patients at Risk for Osteoporosis (APROPOS): Rationale, design, and uptake of online study intervention materialMaria I Danila, Ryan C Outman, Elizabeth J Rahn, et al.
Plos Medicine|May 9, 2019
Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trialJasvinder A Singh, Liana Fraenkel, Candace Green, et al.
Arthritis Care & Research|April 5, 2012
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritisJasvinder A Singh, Daniel E Furst, Aseem Bharat, et al.
The Lancet. Diabetes & Endocrinology|November 3, 2019
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension studyMichael R McClung, Michelle L O'Donoghue, Socrates E Papapoulos, et al.
Annals of the Rheumatic Diseases|January 24, 2020
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 updateJosef S Smolen, Robert B M Landewé, Johannes W J Bijlsma, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 4, 2025
Asia-Pacific consensus for the management of osteoporosis in menChun-Feng Huang, Cheng-Jung Ho, Sung-Yen Lin, et al.
Pageof 38